BNP And NTproBNP Market Analysis, Business Growth, Opportunities And Forecast 2024-2033

The bnp and ntprobnp market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to aging population, clinical utility in heart failure diagnosis, advancements in cardiovascular medicine, focus on preventive healthcare.

The bnp and ntprobnp market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing cardiovascular disease burden, integration into point-of-care testing, expanding applications in other medical conditions, personalized medicine approaches, telemedicine and remote monitoring. Major trends in the forecast period include technological advancements in assay methods, personalized medicine approaches, biomarker in predicting prognosis, emergence of novel biomarkers, global standardization efforts.

Market Overview -
A BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) tests refer to a test that measures the amount of BNP or its prohormone NT-proBNP in the bloodstream, detecting heart failure and other heart-related ailments. BNP, or NT-proBNP, are natriuretic peptides that play a crucial role in regulating circulation. The high levels of BNP or NT-proBNP are indications of underlying heart disease (abnormality in pumping blood).

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10673&type=smp

Cardiovascular Disease Prevalence Fuels Growth
The rising prevalence of cardiovascular diseases is expected to propel the growth of the BNP and NTproBNP market going forward. Cardiovascular diseases are disorders that affect the heart and blood vessels, such as peripheral arterial disease, cerebrovascular disease, coronary heart disease, and others. BNP and NTproBNP tests deal with heart health and safety monitoring, determining factors contributing to the cardiovascular disease before disease occurrence, thereby helping in taking preventative measures and reducing the chance of mortality. For instance, in March 2022, according to the Office for National Statistics, a UK-based statistics authority that reports directly to the UK Parliament, the number of deaths due to a heart attack as an underlying cause increased from 19,440 in 2020 to 20,061 in 2021. The rising prevalence of cardiovascular diseases is driving the BNP and NTproBNP markets.

Competitive Landscape -
Major companies operating in the bnp and ntprobnp market report are Abbott Laboratories,Gentian Diagnostics ASA,Siemens AG,PerkinElmer Inc.,Biomerieux SA,Quidel Corporation,Bio-Rad Laboratories Inc.,F Hoffman La Roche Ltd.,CTK Biotech Inc.,RayBiotech Life Inc.,BHR Pharmaceuticals Ltd.,Getein Biotech Inc.,VACURE Biotechnology Co. Ltd.,Bio-Techne Co.,Xiamen Biotime Biotechnology Co. Ltd.,Scripps Laboratories Inc.,Danaher Corporation,Beckman Coulter Inc.,Thermo Fisher Scientific Inc.,Randox Laboratories Ltd.,LSI Medience Corporation,Shionogi & Co. Ltd.,Radiometer Medical ApS,Ortho Clinical Diagnostics,Tosoh Corporation,Aidian Oy,Shenzhen Mindray Bio-Medical Electronics Co. Ltd.,Becton Dickinson and Company,Acon Laboratories Inc.,Response Biomedical Corp.,Nanomix Inc.,Cepheid Inc.,Alere Inc.

Innovative Diagnostics Propel Market Advancements
Product innovation is a key trend gaining popularity in the BNP and NTproBNP markets. Major companies in the BNP and NTproBNP markets are introducing innovative products to sustain their position in the market. For instance, in May 2023, Randox Laboratories, a UK-based health, toxicology, and diagnostics company, launched a BNP1-32 diagnostic test for the diagnosis of heart failure. The automated test measures levels of BNP (B-type natriuretic peptide), a protein produced by the heart and blood vessels, with high sensitivity and specificity. This control is used with the Acusera range of third-party controls and Acusera 24.7 software that supports monitoring and representing QC data. The BNP control provides an independent and unbiased assessment of analytical performance, ensuring reliable and accurate testing for BNP.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report

Key Segments -
The bnp and ntprobnp market covered in this report is segmented -
1) By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide)
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.